CHIEF EXECUTIVE OFFICER
Toxicology
BottomLine Termite and Pest
Albania
Stephen, the founder of Evgen Pharma, has over 20 years’ commercial experience in life science industries, focusing on the commercialisation of new technology. He was the founder of Provexis plc, a nutraceutical company, and was its chief executive at the time of its admission to AIM in 2005. Prior to that, Stephen was a principal executive with ANGLE plc, the AIM quoted technology commercialisation company, having previously held a business development role with Manchester Biotech (now University of Manchester Innovation Company), one of the largest campus-based incubators in Europe; in these roles he helped establish a portfolio of drug discovery and development businesses. Stephen has a BSc in Biology (York), a PhD in Applied Biochemistry (Nottingham) and an MBA with distinction (Nottingham). He is a Fellow of the Royal Society of Medicine and an alumni of the Royal Commission for the Exhibition of 1851.
Drug delivery